Hikma Pharmaceuticals PLC

LSE:HIK

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HIK's stock price target?

Price Target

2 316.93 GBX

According to Wall Street analysts, the average 1-year price target for HIK is 2 316.93 GBX with a low forecast of 1 898.8 GBX and a high forecast of 2 908.5 GBX.

What is Hikma Pharmaceuticals PLC's Revenue forecast?

Projected CAGR

5%

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's revenue is 9%. The projected CAGR for the next 3 years is 5%.

What is Hikma Pharmaceuticals PLC's Operating Income forecast?

Projected CAGR

7%

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's operating income is 6%. The projected CAGR for the next 3 years is 7%.

What is Hikma Pharmaceuticals PLC's Net Income forecast?

Projected CAGR

43%

For the last 8 years the compound annual growth rate for Hikma Pharmaceuticals PLC's net income is -3%. The projected CAGR for the next 3 years is 43%.